首页 › 膀胱癌 › 加利福尼亚州 › Los Angeles
Los Angeles CA 膀胱癌临床试验
24项针对 膀胱癌的研究正在 Los Angeles及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
招募中2 期
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
招募中1 期
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
招募中2 期
- USC Norris Comprehensive Cancer Center ( Site 0123), Los Angeles
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
招募中2 期
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
招募中1 期
- Ronald Reagan UCLA Medical Center, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
招募中1/2 期
- START Los Angeles, LLC, Los Angeles
- Los Angeles Cancer Network - Century City, Los Angeles
- (IRB# 26-0433) Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
- 以及另外 1 项
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
招募中3 期
- TRIO-US (Translational Research in Oncology-US), Los Angeles
- UCLA Hematology/Oncology - Santa Monica, Los Angeles
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
招募中1 期
- USC/Norris Comprehensive Cancer Center, Los Angeles
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
招募中2/3 期
- Research Site, Los Angeles
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
招募中1 期
- University of California, Los Angeles (UCLA) - Division of Hematology-Oncology, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
招募中1 期
- The Angeles Clinic and Research Institute, Los Angeles
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
招募中1/2 期
- USC/Norris Comprehensive Cancer Center, Los Angeles
- Tower Urology, Los Angeles
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
招募中2 期
- UCLA Downtown Los Angeles Primary & Specialty Care, Los Angeles
- Kaiser Permanente Los Angeles Medical Offices, Los Angeles
- Kaiser Permanente West Los Angeles Medical Center, Los Angeles
- 以及另外 6 项
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
招募中1 期
- USC Norris Comprehensive Cancer Center, Los Angeles
Predicting BCG Response
招募中观察性研究
- Cedars-Sinai Medical Center, Los Angeles
- UCLA, Los Angeles
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- Ronald Reagan UCLA Medical Center, Los Angeles
- The Regents of the University of California, Los Angeles
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
招募中
- Urology Group of Southern California, Los Angeles
- Comprehensive Urology, Los Angeles
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- USC - Norris Comprehensive Cancer Center, Los Angeles
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
招募中观察性研究
- Cedars-Sinai Medical Center, Los Angeles
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
招募中观察性研究
- Cedars-Sinai Medical Center, Los Angeles
- UCLA Medical Center, Los Angeles
Blue Light Cystoscopy With Cysview® Registry
招募中观察性研究
- USC/Norris Comprehensive Cancer Center, Los Angeles
- University of California Los Angeles, Los Angeles
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
招募中
- Cedars-Sinai Medical Center (CSMC), Los Angeles
- University of California Los Angeles, Los Angeles
Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
招募中
- UCLA, Los Angeles
其他城市的 膀胱癌试验
- New York City, NY35 项研究
- Houston, TX31 项研究
- Nashville, TN31 项研究
- Dallas, TX27 项研究
- Washington, DC26 项研究
- Boston, MA26 项研究
- Baltimore, MD24 项研究
- St. Louis, MO22 项研究
- Seattle, WA21 项研究
- Edison, NJ21 项研究
- Philadelphia, PA21 项研究
- Chicago, IL21 项研究
Los Angeles的其他研究
- 非小细胞肺癌87 项研究
- 癌症（所有类型）74 项研究
- 乳腺癌73 项研究
- 前列腺癌61 项研究
- 结直肠癌59 项研究
- 转移性癌症57 项研究
- 卵巢癌50 项研究
- 肺癌45 项研究
- 头颈鳞状细胞癌42 项研究
- 胰腺癌35 项研究
- 子宫内膜癌34 项研究
- 黑色素瘤34 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。